Search

everythinglearnresearchcommunity

for

Search:↓

5-Alpha-Reductase inhibitors shorten COVID-19 recovery time in men.

Dutasteride can stabilize hair loss in patients with frontal fibrosing alopecia, but its safety in women is unclear, so use it with caution.

Taking 5 alpha reductase inhibitor medication slightly increases the risk of depression, especially as you get older.

Men taking 5-alpha reductase inhibitors for prostate issues may be less likely to experience severe COVID-19, but it doesn't prevent ICU admission or death.

Taking 5-alpha reductase inhibitors does not increase the risk of breast cancer in men.

Using 5-alpha reductase inhibitors may increase the risk of mild depression.

Finasteride 1mg linked to diverse symptoms; other treatments improve erectile function in rats.

Medications for hair loss and prostate issues can significantly increase the risk of sexual side effects and other negative symptoms.

The authors suggest that 5-α-reductase inhibitors, like dutasteride, are effective in treating frontal fibrosing alopecia and should be the first-line treatment, with other options for severe cases. They also recommend further research on Janus kinase inhibitors.

5-alpha reductase inhibitors can cause sexual, neurologic, endocrine, and cardiovascular side effects, but these are rare and usually stop after ending treatment.

Taking 5-alpha reductase inhibitors does not increase breast cancer risk in men.

More research needed to confirm finasteride as standard treatment for FFA.

Dutasteride and finasteride can help increase hair growth gene expression but need further improvement.

Medicines for enlarged prostate may raise the risk of breast growth and tenderness but not breast cancer.

Using 5-alpha reductase inhibitors may lower the risk of breast cancer in females.

A higher genetic risk score increases the chance of getting benign prostatic hyperplasia and affects treatment outcomes in Han Chinese men.

Finasteride reduces prostate cancer risk but may increase high-grade tumors; new drugs and better diagnosis are in development, but funding and industry commitment are challenges.

Finasteride and dutasteride do not significantly change beard thickness in men.

5-alpha-reductase inhibitors lower PSA density but higher PSA density indicates disease progression.

Finasteride and dutasteride are effective in treating male hair loss but can cause sexual side effects and birth defects.

5-Alpha Reductase Inhibitors are effective for male hair loss and some skin conditions, but their effectiveness in women and safety concerns require careful use.

Canadian lawsuits involving 5-alpha-reductase inhibitors are related to persistent erectile dysfunction side effects, with no judgments against companies yet.

Prescriptions for 5-alpha reductase inhibitors dropped significantly after the FDA's safety warning, especially for men with benign prostatic hyperplasia.

Finasteride reduces prostate cancer risk but may increase high-grade tumors and has side effects; biopsy methods have similar outcomes; psychosocial factors affect sexual recovery post-surgery.

5-alpha reductase inhibitors may help protect the brain and gut in Parkinson's disease.

Men taking dutasteride may have a higher risk of age-related macular degeneration.

PrEP doesn't increase STI risk in high-risk men, anti-androgen drugs may lower ICU admission for male COVID-19 patients, a 3-point injection is better for crow's feet, and the 'Geriatric-8' tool could help assess frailty in older skin cancer patients.

5-alpha reductase inhibitors slightly reduce urinary symptoms and may lower surgery and acute retention risks in men.

The document concludes that the risk of sexual side effects from 5-alpha-reductase inhibitors is low and often temporary, but more research is needed on potential permanent effects.

Dutasteride is effective for treating hair loss.